Real-time enrollment status for this relapsing multiple sclerosis clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT06846281 |
| Recruiting Status | Recruiting |
| Condition | Relapsing Multiple Sclerosis |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 21, 2026: Clinical trial NCT06846281 is currently recruiting participants. This phase3 study for relapsing multiple sclerosis is actively seeking new participants at 44 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06846281 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06846281 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.